
Mygris 60mg Tablet
Marketer
Bharat Serums & Vaccines Ltd
Salt Composition
Pyridostigmine (60mg)
Overview Mygris 60mg Tablet
Neuramin 60mg tablets treat myasthenia gravis (muscle weakness and fatigue), paralytic ileus (intestinal paralysis), and post-surgical urinary retention. It enhances muscle strength, improves bowel movements, and stimulates bladder function. Take Neuramin 60mg on an empty stomach, consistently at the same time daily, as prescribed. Missed doses should be taken immediately upon recall; avoid skipping doses and complete the entire course. Discontinue only under medical supervision. Common side effects include nausea, hypersalivation, diarrhea, blurred vision, dyspnea, lacrimation, abdominal discomfort, and altered micturition frequency. Other potential side effects: sweating, headache, rhinorrhea, and pyrosis. Dizziness and somnolence may also occur; avoid activities requiring concentration, like driving. Before use, inform your physician of any kidney issues, Parkinson's disease, asthma, or gastrointestinal problems. Monitor blood pressure, as it may drop; consult your doctor if concerning. Due to potential diarrhea, maintain adequate hydration. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor prior to commencing treatment.
Primary Ingredients of Mygris 60mg Tablet
No text provided to rephrase.
Uses of Mygris 60mg Tablet
Managing myasthenia gravis, paralytic ileus, and postoperative urinary retention.
Major Benefits of Mygris 60mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Mygris 60mg Tablet on an empty stomach.
Common Side effects of Mygris 60mg Tablet:
- Nausea
- Excessive salivation
- Diarrhea
- Blurred vision
- Breathlessness
- Watery eyes
- Abdominal pain
- Altered frequency of urination
- Sweating
- Headache
- Dizziness
- Runny nose
- Heartburn
- Gastro-esophageal reflux disease
- Paresthesia (tingling or pricking sensation)
- Muscle twitching
- Weakness
- Muscle cramp
- Increased bronchial secretions
How to use Mygris 60mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the 60mg Mygris tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
How Mygris 60mg Tablet works:
Mygris 60mg tablets enhance acetylcholine neurotransmission, boosting communication between nerve and muscle cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Mygris 60mg Tablet may pose unknown risks. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The use of Mygris 60mg Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Mygris 60mg tablets appear compatible. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking a Mygris 60mg Tablet can cause drowsiness, blurred vision, and dizziness. Driving is unsafe under these conditions. This medication may impair visual acuity, hindering safe operation of vehicles or machinery. Avoid driving or using machinery if your vision is affected.
KidneyCAUTION
Individuals with kidney impairment should use Mygris 60mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Mygris 60mg Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Mygris 60mg Tablet :
Should you forget a Mygris 60mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mygris 60mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Pyridinium N-Methyl Derivatives |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Action Class | Carbamate cholinesterase inhibitors |
